CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Millions	Total	Common Stock And Surplus	Retained Earnings (Deficit)	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at May. 29, 2022		123,900
Beginning balance at May. 29, 2022	$ 2,198.2	$ 2,226.0	$ (25.9)	$ (1.9)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	666.8		666.8
Other comprehensive income (loss)	2.0			2.0
Dividends declared	(446.7)		(446.7)
Stock option exercises (in shares)		200
Stock option exercises	10.0	$ 10.0
Stock-based compensation	27.8	$ 27.8
Repurchases of common stock (in shares)		(3,300)
Repurchases of common stock	(423.5)	$ (59.9)	(363.6)
Issuance of stock under Employee Stock Purchase Plan and other plans (in shares)		300
Issuance of stock under Employee Stock Purchase Plan and other plans	8.3	$ 8.3
Other	1.0	$ 1.0
Ending balance (in shares) at Feb. 26, 2023		121,100
Ending balance at Feb. 26, 2023	2,043.9	$ 2,213.2	(169.4)	0.1
Beginning balance (in shares) at Nov. 27, 2022		121,900
Beginning balance at Nov. 27, 2022	2,020.9	$ 2,214.6	(199.7)	6.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	286.6		286.6
Other comprehensive income (loss)	(5.9)			(5.9)
Dividends declared	(147.8)		(147.8)
Stock option exercises (in shares)		100
Stock option exercises	3.8	$ 3.8
Stock-based compensation	7.9	$ 7.9
Repurchases of common stock (in shares)		(900)
Repurchases of common stock	(124.3)	$ (15.8)	(108.5)
Issuance of stock under Employee Stock Purchase Plan and other plans	2.8	2.8
Other	(0.1)	$ (0.1)
Ending balance (in shares) at Feb. 26, 2023		121,100
Ending balance at Feb. 26, 2023	2,043.9	$ 2,213.2	(169.4)	0.1
Beginning balance (in shares) at May. 28, 2023		121,100
Beginning balance at May. 28, 2023	2,201.5	$ 2,230.8	(32.5)	3.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	719.5		719.5
Other comprehensive income (loss)	26.5			26.5
Dividends declared	$ (475.5)		(475.5)
Stock option exercises (in shares)	350	300
Stock option exercises	$ 28.3	$ 28.3
Stock-based compensation	31.0	$ 31.0
Repurchases of common stock (in shares)		(2,300)
Repurchases of common stock	(356.6)	$ (43.5)	(313.1)
Issuance of stock under Employee Stock Purchase Plan and other plans (in shares)		300
Issuance of stock under Employee Stock Purchase Plan and other plans	8.7	$ 8.7
Other	(2.5)	$ (2.5)
Ending balance (in shares) at Feb. 25, 2024		119,400
Ending balance at Feb. 25, 2024	2,180.9	$ 2,252.8	(101.6)	29.7
Beginning balance (in shares) at Nov. 26, 2023		119,500
Beginning balance at Nov. 26, 2023	2,039.7	$ 2,240.8	(228.5)	27.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	312.9		312.9
Other comprehensive income (loss)	2.3			2.3
Dividends declared	(157.3)		(157.3)
Stock option exercises (in shares)		100
Stock option exercises	8.1	$ 8.1
Stock-based compensation	4.9	$ 4.9
Repurchases of common stock (in shares)		(200)
Repurchases of common stock	(32.7)	$ (3.9)	(28.8)
Issuance of stock under Employee Stock Purchase Plan and other plans	3.0	3.0
Other	0.0	$ (0.1)	0.1
Ending balance (in shares) at Feb. 25, 2024		119,400
Ending balance at Feb. 25, 2024	$ 2,180.9	$ 2,252.8	$ (101.6)	$ 29.7